ACRC Building


Summary: This is an approximately 19-week clinical research study to assess the safety and effectiveness of an investigational (not approved by the FDA) medication for people who suffer from IBS with frequent diarrhea (also known as diarrhea-predominant IBS) and abdominal pain

To qualify you must: Benefits:

Qualified participants may receive study-related physical examinations, medical testing, and study medication or placebo.

 Compensation up to $385.00 for time and travel is also available.

If you are interested in this study, please contact
ACRC/Arizona Clinical Research Center, Inc.
1825 N. Kolb Rd.
Tucson, AZ 85715
Phone: (520) 290-9896
Fax: (520) 290-2508

Participants cannot be enrolled in the clinical study until they have signed an informed consent form, completed screening procedures, and been fully evaluated at the study site.

Return Home